Iridex (IRIX) Interest Expenses (2012 - 2013)
Iridex (IRIX) posted Interest Expenses of $171000.0 for Q4 2013, up 101.18% on a QoQ basis from $85000.0 in Q3 2013, and up 850.0% year-over-year from $18000.0 in Q4 2012.
Powered by 
Analysis
Iridex (IRIX) Interest Expenses (2012 - 2013) Analysis & Trends
Iridex has reported Interest Expenses for 2 years, with the latest figure at $171000.0 in Q4 2013.
- On a quarterly basis, Interest Expenses rose 850.0% year-over-year to $171000.0 in Q4 2013; TTM through Dec 2013 was $371000.0, a N/A change from a year earlier, with the FY2013 full-year figure at $371000.0, up 76.67% from the prior year.
- Interest Expenses was $171000.0 for Q4 2013 at Iridex, up from $85000.0 in the prior quarter.
- The five-year high for Interest Expenses was $171000.0 in Q4 2013, with the low at $18000.0 in Q4 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | - |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 186.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 141.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 96.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | - |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -53.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 15.80 Mn |
| 10 | Iridex | 12.22 Mn | 7.54 Mn | 4.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 28, 2013 | 171,000.00 |
| Sep 28, 2013 | 85,000.00 |
| Jun 29, 2013 | 97,000.00 |
| Dec 29, 2012 | 18,000.00 |
| Sep 29, 2012 | 117,000.00 |
| Jun 30, 2012 | 48,000.00 |